Urinary Tract Infections

a.     Carbapenem mediated drug resistance

b.     Epidemiology of complicated UTI

c.     Newly emerging uropathogens

d.     Mechanisms of resistance in pan drug resistant Acinetobacter baumanii  uropathogens

e.     Enterococcal UTI

Enteric Infections:

a.     Newly emerging enteric pathogens like Listeriosis and Yerisiniosis

b.     Epidemiology, prevalence and drug resistance of Aeromonas species

As PI

a.     Occurrence of asymptomatic bacteriuria and symptomatic UTI in preschool and healthy school going children in Chandigarh (DST Chandigarh)

b.     Prevalence of Carbapenem-resistant Enterobacteriaceae carriage in preschool and healthy school going children in Chandigarh (DST Chandigarh)

As Co-PI

1. A study of serotypic differences in innate and adaptive immune responses in shigellosis in human (ICMR)
2. Colonization factor analysis and molecular epidemiology of Enterotoxigenic E. coli (ICMR)
3. Integrated Surveillance of Antimicrobial Resistance (AGISAR) for foodborne pathogens(WHO Indo-US)

a.     Surveillance of KPC and NDM-1 producing Carbapenem-resistant members of the family Enterobacteriaceae

b.     Epidemiology and molecular mechanisms of drug resistance in pan drug resistant Acinetobacter baumanii  uropathogens

1.     Comparative susceptibility of imipenem, meropenem and ertapenem and correlation with NDM-1 in uropathogens.

2. Virulence profile and antimicrobial susceptibility of Aeromonas isolated from gastroenteritis over a decade.

3.     Antimicrobial susceptibility and biofilm formation capability of enterococcal strains causing UTI vis a vis colonizing strains and correlation with esp gene.

4. A study of serotypic differences in innate and adaptive immune responses in shigellosis in human (ICMR)
5. Colonization factor analysis and molecular epidemiology of Enterotoxigenic E. coli (ICMR)
6. Integrated Surveillance of Antimicrobial Resistance (AGISAR) for foodborne pathogens(WHO Indo-US)

a.     Urinary Tract Infection

b.     Diarrhoea

1.     Neelam Taneja, Suma B. Appannanavar, Ajay Kumar, GarimaVarma, Yashwant Kumar, Balvinder Mohan and Meera Sharma. Serotype profile andmolecular characterization of antimicrobial resistance in non-typhoidal Salmonella isolatedfrom gastroenteritis cases over nine years, India. J Med Microbiol; 2014;63(1):66-73.

2.     Suma B. Appannanavar, M Biswal, N Rajkumari, Balvinder Mohan andNeelam Taneja. Evaluation of commercial boric acid containing vials for urineculture: Low risk of contamination and cost effectiveness considerations. Ind JPathol Microbiol 2013;56(3),261.

3.     NeelamTaneja, Valerie Lyngdoh, Archa Vermani, Balvinder Mohan et al. Re-emergence ofmulti- drug resistant Shigelladysenteriae with added resistance to Ciprofloxacin in north India and theirplasmid profiles. Ind J Med Res.2005;122:348-354 

4.     TanejaN, Mohan Balvinder and Sharma M. Antimicrobial resistance in selected bacterialenteropathogens in north India. Ind J Med Res.2004;120:39-43

5.     MishraB, Mohan Balvinder and Ratho RK. Heterophile antibody positive infectiousmononucleosis. Ind J Pediatr.2004 ;71:15-18

6.     MohanBalvinder, Dubey ML, Malla N and Kumar R.. Seroepidemiological study oftoxoplasmosis in different sections of population of union territory ofChandigarh. J  Commun Dis. 2002; 34(1):15-22.

7.     ChakrabartiA, Mohan Balvinder, Shrivastava SK, Marak RSK and Ray P. Change in distributionand antibiotic susceptibility of Candida species isolated fromcandidemia cases in a tertiary care center during 1996-2000. Ind J Med Res.2002; 116:5-12.